Scarica l'app Stockscreener
35.56
0.87%
0.305
Dopo l'orario di chiusura:
35.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Bank of America Corp DE Makes New $2.35 Million Investment in Castle Biosciences, Inc. $CSTL - MarketBeat
Precision Trading with Castle Biosciences Inc. (CSTL) Risk Zones - Stock Traders Daily
Low-risk melanoma patients who skipped lymph node biopsy had 99.6% recurrence-free survival at five years. - Stock Titan
Castle Biosciences (CSTL) Study Validates TissueCypher Test's Im - GuruFocus
A test changed doctors’ plans for 90% of patients with the same precancerous esophagus condition. Their risks differed. - Stock Titan
Castle Biosciences CEO sells $512k in stock - Investing.com
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Texas bioscience firm expands in Scottsdale as AZ headcount tops 200 - The Business Journals
New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™ - PR Newswire
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 8,580 Shares - MarketBeat
CSTL Looks 17.2% Overvalued on GF Value™ as Market Prices in Str - GuruFocus
Castle Biosciences opens 55,000 sq ft Arizona lab facility By Investing.com - Investing.com Canada
Castle Biosciences to Open New Lab in Arizona - marketscreener.com
Castle Biosciences opens 55,000 sq ft Arizona lab facility - Investing.com
Castle Biosciences,Opens New Laboratory And Office Facility In Scottsdale, Arizona - TradingView
Castle Biosciences to Open New Laboratory Facility in Scottsdale - PR Newswire
Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL - MarketBeat
Castle Biosciences, Inc. (CSTL) Stock Analysis: A 19.63% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Castle Biosciences Inc (CSTL) Shares Surge 3.7% -- What GF Score of 82 Tells Investors - GuruFocus
Castle Biosciences (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W Sells 6,600 Shares Between $32.32 and $35.14 - Kalkine Media
Castle Biosciences Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock GainEstimate Uncertainty - siam.in
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,600 Shares - GuruFocus
Tobin Juvenal Sells 3,306 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - marketbeat.com
Castle Biosciences (NASDAQ:CSTL) Insider Sells 3,294 Shares of Stock - MarketBeat
6,600 Castle Biosciences (CSTL) shares sold under preset 10b5-1 plan - Stock Titan
Castle Biosciences (NASDAQ:CSTL) Shares Up 4.3%Here's What Happened - MarketBeat
Castle Biosciences TissueCypher Study Shows Improved Risk-Aligned Barrett’s Esophagus Management - Yahoo Finance
CSTL Looks 12.1% Overvalued on GF Value™ - GuruFocus
A study found a test could nearly double closer monitoring or treatment for some Barrett’s patients - Stock Titan
Castle Biosciences (CSTL) CCO plans more stock sales under 10b5-1 plan - Stock Titan
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Preset sale plan at Castle Biosciences (CSTL) covers 29K shares - Stock Titan
Castle Biosciences, Inc.JAAD Publication Shows Improved Performance of DecisionDx-SCC - marketscreener.com
Responsive Playbooks and the CSTL Inflection - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Price Quote Today & Current Price Chart - Capital.com
JAAD Publication Shows Improved Performance of DecisionDx®-SCC - STLtoday.com
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us
Castle Biosciences Inc. (CSTL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - investing.com
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares - Investing.com
Empowered Funds LLC Acquires New Shares in Castle Biosciences, Inc. $CSTL - marketbeat.com
Castle Biosciences (NASDAQ: CSTL) CCO sells 1,730 shares under 10b5-1 plan - Stock Titan
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $412,609.60 in Stock - marketbeat.com
CSTL stock gains as institutional investor builds position and recent results support growth story - ad-hoc-news.de
CSTL Q2 2026 Earnings: Loss Narrows to -$0.07 per Share, Delivering an 83% BeatFull Year Guidance - vinanet.vn
Man Group plc Takes $2.59 Million Position in Castle Biosciences, Inc. $CSTL - MarketBeat
3,291,963 Shares in Castle Biosciences, Inc. $CSTL Purchased by BlackRock Inc. - MarketBeat
(CSTL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Castle Biosciences, Inc. $CSTL Shares Acquired by Algert Global LLC - MarketBeat
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know - Yahoo Finance
Jefferies Financial Group Inc. Acquires New Shares in Castle Biosciences, Inc. $CSTL - MarketBeat
0.97%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):